90 likes | 260 Views
Pharmaprojects New Developments. Wendy Manning Deputy Editor, Pharmaprojects www.pharmaprojects.com. What’s New?. Pharmaprojects v 5.1 launched Aug 2004 Subsequent enhancements Launch of v5.2 planned for Aug 2006 and finally.. Pharmapredict. Pharmaprojects v5.1. Protein target data
E N D
Pharmaprojects New Developments Wendy Manning Deputy Editor, Pharmaprojects www.pharmaprojects.com
What’s New? • Pharmaprojects v 5.1 launched Aug 2004 • Subsequent enhancements • Launch of v5.2 planned for Aug 2006 • and finally.. Pharmapredict
Pharmaprojects v5.1 • Protein target data • Searchable Lipinski “Rule of 5” parameters • Enhanced detailed information searching www.pharmaprojects.com
Subsequent Enhancements • New Stem Cell Classification added • More timely updates • 12 years of Trends data (1995-2006) www.pharmaprojects.com
Upcoming for v5.2 • Data enhancements • Enhanced classification of Licensing Opportunities • NCE Flag • Target Families www.pharmaprojects.com
Target Family Groupings • ENZYMES - subclasses and EC numbers • RECEPTORS - subclasses (2 levels) • HORMONES • CYTOKINES - subclasses • TRANSPORTERS - subclasses and TC numbers www.pharmaprojects.com
Upcoming for v5.2 • Improving Usability • “Quick Search” function • Simplified general method of searching • More logical navigation to Graphs and reports • Links to PubMed abstracts www.pharmaprojects.com
Pharmapredict • Forecasting/Benchmarking tool • Browser-based web application • Pharmaprojects list price subscribers receive preferential rate www.pharmapredict.com
Pharmapredict-analyses • Estimate time to market/launch date • Look at “launch landscape” • Chance of success/attrition rates • Estimated sales data from Evaluate Pharma www.pharmapredict.com